Testing for hepatitis C virus infection should be routine for persons at increased risk for infection.
about
Hepatitis C: a review for primary care physiciansHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveEconomic evaluation of screening programs for hepatitis C virus infection: evidence from literatureSelf-reported hepatitis C virus antibody status and risk behavior in young injectorsThe Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus InfectionPrevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central BrazilDiagnosis, management, and treatment of hepatitis C: an updateDevelopment and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.Psychiatric care of the patient with hepatitis C: a review of the literature.American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.Hepatitis infection in the treatment of opioid dependence and abuse.The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.Screening for hepatitis C in average and high-risk populations of Qatar using rapid point-of-care testingHepatitis C -- identifying patients with progressive liver injury.Hepatitis C screening: getting it right.Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.In the clinic. Hepatitis C.Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.Toward a simple risk assessment screening tool for HCV infection in Egypt.Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.Screening in liver disease.Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.Outcome of screening for hepatitis C virus infection based on risk factors.Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients.[Early diagnosis of liver diseases].Analysis of a hepatitis C screening programme for US veterans.Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004.Assessment of Knowledge, Attitudes, and Practices Regarding Chronic Hepatitis C Treatment and Its Challenges: A Survey of Internal Medicine Residents in a Community Hospital.
P2860
Q22306040-4DCF02A4-5A7A-469E-82CE-C4D55D7CC902Q26782033-4D5B5EF3-ADBF-4DE2-97CC-1A4479EE26ECQ26827517-0D39ACE3-6105-4104-A4C0-26F09F32F44AQ26998567-FCF6B2D8-985D-46C3-8E2C-FFF162AB9912Q27478003-4C7A18BA-D452-4E8D-AB20-15FD3B82C3F6Q27486939-812D4AA6-8CC3-41DF-A3FA-368CEAD247BFQ27489255-4EFB0D29-2DAE-4F53-81D6-67DCAA602342Q29619682-85C848CA-3401-44C2-9CFE-D827E2806291Q33572715-E76F0314-A729-4EAA-BBC3-237393588C4DQ33591192-738BA7C5-C61A-44E8-9BA5-FB2A35D32D09Q33977173-49EE8DD3-1FD7-45FB-AD92-E1221E486240Q34088245-901D94A3-65B4-4D5F-88C5-80EBDE9B442CQ34743058-09F1C886-67E6-4BF8-8F73-2E96F350E298Q34782898-773BE5FC-4599-444D-B4AF-CEB7EECEC298Q34873114-9DA8B47B-7D12-440B-B4C8-D0E89B5F8DA3Q35389163-4EF6AD5B-166E-47AD-8FC4-0F0FE9AAEFD9Q35696958-11C87110-0F72-4B2E-BB8C-793BA0E6595FQ35926098-90BCF100-6158-4242-8115-19DA1BC595DBQ36382231-0F0DAE62-A898-4109-B978-5CD33578554FQ36575211-C17BC5E6-ACA8-47C7-A35C-9FABBF00865BQ36758587-957B8114-A2A0-4F24-8995-40709DC022FAQ37180035-DB32542F-F2DA-4F24-88D1-0B35E7958962Q37244221-A6B317A9-9144-4145-99A7-9FE934C38507Q37618606-2B9D0241-0602-41C8-A54C-D114A78BC302Q38896137-9A4AF654-257A-417B-9C7A-4328F85CAC67Q39349274-FCA6024C-DFC6-4EBD-89EA-EFE66D5AE885Q42726447-B4DF6A04-AF73-4116-88FF-EE05ABB2B881Q42996966-3B3E8468-2CC8-4299-AB52-C5F4A76A2113Q43040992-6F34F450-DE6D-4425-8A74-E518B4C0AFA0Q43419544-9AFDE9E1-65DA-4D2C-96DA-FD5D11AF5337Q44393867-A9778EA0-6C56-4DFD-A30A-0D1D6C7E9552Q45296664-1FF380ED-CFE9-4FD0-88DC-EF2F9FC8101EQ45332846-EEF85845-43F6-4BD7-9F3D-91116CC00BB9Q45415186-DF2766E9-579B-4C03-A1D0-5937FB620647Q55041475-C69ECC7D-59D6-49F4-A9C0-FCA045617DF7
P2860
Testing for hepatitis C virus infection should be routine for persons at increased risk for infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Testing for hepatitis C virus ...... increased risk for infection.
@ast
Testing for hepatitis C virus ...... increased risk for infection.
@en
type
label
Testing for hepatitis C virus ...... increased risk for infection.
@ast
Testing for hepatitis C virus ...... increased risk for infection.
@en
prefLabel
Testing for hepatitis C virus ...... increased risk for infection.
@ast
Testing for hepatitis C virus ...... increased risk for infection.
@en
P2093
P1476
Testing for hepatitis C virus ...... increased risk for infection.
@en
P2093
Bruce R Bacon
David L Thomas
Leonard B Seeff
Michael O Rigsby
Miriam J Alter
P304
P356
10.7326/0003-4819-141-9-200411020-00013
P407
P577
2004-11-01T00:00:00Z